Search

The review provides the opinions of scientists on the results of pharmaco- economy analysis of antihypertension drugs usage in different countries. The necessity underlined for the concentration of attention on analytic approach and financing of the State sector of healthcare support on the availability of treatment and prevention of the main chronic diseases. The parameters of economic assessment of efficacy of different antihypertension drugs are not only the criterial for rational usage of restricted resources of healthcare system, but also help to choose the exact drug in clinical situation to provide to the patient the best life quality with real economic wealth.

The review focuses on the opinions of scientists and on the results of studies of molecular mechanisms in gestation hypertension pathogenesis as on the influence of social, psychosomatic and anamnestic factors on the stages of this pathology development.